Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction
Clinical trial NCT02929329 · COMPLETED
Trial details
- NCT number
- NCT02929329
- Sponsor
- Cytokinetics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-06
- Primary completion
- 2020-09-14
- Enrollment
- 8256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.